Australia - English - Department of Health (Therapeutic Goods Administration)

sohume pty ltd - octyl methoxycinnamate, quantity: 70 mg/g; oxybenzone, quantity: 40 mg/g; butyl methoxydibenzoylmethane, quantity: 50 mg/g; octocrylene, quantity: 60 mg/g - cream - excipient ingredients: purified talc; isopropyl myristate; acetylated lanolin; glyceryl monostearate; cetomacrogol 1000; alkyl (c12-15) benzoate; glycerol; stearic acid; purified water; aluminium magnesium silicate; trolamine; propylene glycol; iron oxide yellow; iron oxide black; iron oxide red; titanium dioxide; phenoxyethanol; caprylyl glycol - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 broad spectrum high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Australia - English - Department of Health (Therapeutic Goods Administration)

sohume pty ltd - octocrylene, quantity: 60 mg/g; oxybenzone, quantity: 40 mg/g; octyl methoxycinnamate, quantity: 70 mg/g; butyl methoxydibenzoylmethane, quantity: 50 mg/g - cream - excipient ingredients: iron oxide yellow; propylene glycol; trolamine; alkyl (c12-15) benzoate; purified talc; purified water; acetylated lanolin; stearic acid; glycerol; iron oxide black; isopropyl myristate; cetomacrogol 1000; aluminium magnesium silicate; iron oxide red; glyceryl monostearate; titanium dioxide; phenoxyethanol; caprylyl glycol - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 broad spectrum high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Australia - English - Department of Health (Therapeutic Goods Administration)

sohume pty ltd - oxybenzone, quantity: 40 mg/g; butyl methoxydibenzoylmethane, quantity: 50 mg/g; octyl methoxycinnamate, quantity: 70 mg/g; octocrylene, quantity: 60 mg/g - cream - excipient ingredients: trolamine; purified water; iron oxide yellow; aluminium magnesium silicate; stearic acid; propylene glycol; cetomacrogol 1000; isopropyl myristate; glycerol; titanium dioxide; purified talc; alkyl (c12-15) benzoate; iron oxide black; iron oxide red; glyceryl monostearate; acetylated lanolin; phenoxyethanol; caprylyl glycol - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 broad spectrum high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Australia - English - Department of Health (Therapeutic Goods Administration)

sohume pty ltd - octocrylene, quantity: 70 mg/g; phenylbenzimidazole sulfonic acid, quantity: 20 mg/g; oxybenzone, quantity: 30 mg/g; butyl methoxydibenzoylmethane, quantity: 25 mg/g - cream - excipient ingredients: ethylhexylglycerin; iodopropynyl butylcarbamate; phenoxyethanol; purified water; disodium edetate; dl-alpha-tocopheryl acetate; carbomer u-10; potassium cetyl phosphate; cetostearyl alcohol; alkyl (c12-15) benzoate; sodium hydroxide; glyceryl monostearate; sorbitan stearate; glycerol - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 plus broad spectrum very high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 25 mg - nortriptyline hydrochloride, usp is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. monoamine oxidase inhibitors (maois) the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see  w arnings   and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings   and dosage and administration ). hypersensitivity to tricyclic antide

United States - English - NLM (National Library of Medicine)

proficient rx lp - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 50 mg - nortriptyline hydrochloride, usp is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. monoamine oxidase inhibitors (maois) the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings  and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings  and dosage and administration ). hypersensitivity to tricyclic antidepressants cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a

United States - English - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 25 mg - nortriptyline hydrochloride capsules are indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see   warnings and dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recov

United States - English - NLM (National Library of Medicine)

american health packaging - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 10 mg - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated ( see warnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome ( see warnings and dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recov

United States - English - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 10 mg - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see  warnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see  warnings  and  dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recovery peri

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 10 mg - nortriptyline hydrochloride capsules are indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. monoamine oxidase inhibitors (maois) the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see  warnings  and  dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see  warnings  and  dosage and administration ). hypersensitivity to tricyclic antidepressants cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is